About Universitätsklinikum Tübingen Medizinische Klinik I
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Universitätsklinikum Tübingen Medizinische Klinik I
During the past decade, Universitätsklinikum Tübingen Medizinische Klinik I conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Tübingen Medizinische Klinik I"
#1 collaborator was "Hannover Medical School" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Universitätsklinikum Tübingen Medizinische Klinik I
According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Tübingen Medizinische Klinik I" are
"Acute Coronary Syndrome" (1 trials), "Acute Myeloid Leukemia (AML)" (1 trials), "Coronary Artery Disease" (1 trials), "Hepatitis C, Chronic" (1 trials) and "Metastatic or Locally Advanced Malignancies" (1 trials). Many other conditions were trialed in "Universitätsklinikum Tübingen Medizinische Klinik I" in a lesser frequency.
Clinical Trials Intervention Types at Universitätsklinikum Tübingen Medizinische Klinik I
Most popular intervention types in "Universitätsklinikum Tübingen Medizinische Klinik I" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Alectinib" (1 trials), "Atezolizumab" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials), "Cobimetinib" (1 trials) and "Cytarabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universitätsklinikum Tübingen Medizinische Klinik I
The vast majority of trials in "Universitätsklinikum Tübingen Medizinische Klinik I" are
4 trials for "All" genders.
Clinical Trials Status at Universitätsklinikum Tübingen Medizinische Klinik I
Currently, there are NaN active trials in "Universitätsklinikum Tübingen Medizinische Klinik I".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Universitätsklinikum Tübingen Medizinische Klinik I,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsklinikum Tübingen Medizinische Klinik I, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".